Abstract:Objective: To explore the clinical characteristics of early-onset preeclampsia (PE) combined with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, and to improve the capacity for early diagnosis and treatment. Methods: Pregnant women who received treatment at Women's Hospital, School of Medicine, Zhejiang University between March 2014 and October 2021 were retrospectively enrolled. There were two patient groups, the HELLP group consisting of 70 cases of early-onset PE combined with HELLP syndrome and the control group consisting of 140 cases of early-onset PE without HELLP syndrome. Patients in the two groups were matched by age. The general clinical data, characteristics of pathogenesis, and laboratory findings of the patients were collected and the perinatal outcomes of the two groups were compared and analyzed. Results: 1) There was no significant difference in gravidity, pre-delivery body mass index, years from the last delivery, and family history of diabetes mellitus and hypertension between the two groups. 2) The highest systolic blood pressure, highest diastolic blood pressure during the pregnancy, and the postpartum hospital length-of-stay ( P<0.001) in the HELLP group were higher than those in the control group. The gestational age at the time of the diagnosis of PE ( P=0.001) and the gestational age at delivery ( P<0.001) in the HELLP group were significantly earlier than those in the control group. The difference between the gestational age at the time of blood pressure elevation and that at the time of delivery ( P<0.001), and the gestational age difference between the diagnosis of early-onset PE and delivery ( P=0.027) were lower than those in the control group. The incidences of eclampsia in the HELLP group, pleural effusion, and ascites were higher than those of the control group. 3) Neonates in the HELLP group had a higher probability of being admitted to NICU and developing cyanotic/pale asphyxia ( P<0.001). 4) Before the termination of pregnancy, the HELLP group had higher levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, creatinine, urea, random glucose, lactate dehydrogenase, activated partial thromboplastin time, and the last 24-hour urine protein quantification than those of the control group (all P<0.05), while the platelet (PLT) counts were significantly lower than those of the control group ( P<0.001). 5) There was a significant correlation between PLT counts in the second trimester and the onset of HELLP syndrome ( P=0.006), with the area under the ROC curve reaching 0.746 (95% CI: 0.596-0.897). Conclusion: In comparison with early-onset PE patients without HELLP syndrome, patients with early-onset PE combined with HELLP syndrome are diagnosed for PE at an earlier gestational age, have higher blood pressure, are more prone to serious pregnancy complications, and have longer postpartum hospital length-of-stay and worse neonatal outcomes. Close monitoring of PLT counts of early-onset PE patients in the second trimester may help predict subsequent HELLP syndrome.

Analysis of hematocrit in 193patients with early-onset severe preeclampsia and late-onset severe preeclampsia

Early- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings according to the New ISHHP Criteria

Study on Correlation between Changes in Coagulation and Fibrinolysis Related Factors and Incidence of Severe Pre-eclampsia

Body mass index, lipid profile, and endothelial dysfunction gene polymorphism in women with early-onset and late-onset preeclampsia

The relationship between maternal hematocrit and pregnancy outcome in women with preeclampsia

Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China

Changes of serum cardiotropin Ⅰ and cystatin C in preeclampsia and clinical significance thereof

Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

[Changes of serum cardiotrophin I and cystatin C in preeclampsia and clinical significance thereof].

Lipidomic signatures in patients with early-onset and late-onset Preeclampsia

A Study of Heat Shock Protein 90 and Serum CCL21 Expression in Pregnant Women with Preeclampsia

Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia

[Clinical Comparative Analysis of Early-Onset Preeclampsia Combined with HELLP Syndrome]

Analyzing clinical features and forecasting pregnancy outcomes of early-onset severe preeclampsia

Study on the correlations of coagulation indexes, TNF-α and hemolysis, elevated liver enzymes and thrombocytopenia syndrome in preeclampsia patients

Parallel Assessment Of Circulatory Fetal Dna And Corticotropin-Releasing Hormone Mrna In Early- And Late-Onset Preeclampsia

Investigation of Serum Heat-shock Protein 70 Antibody in the Diagnosis and Evaluation of Seriousness of Preeclampsia

Study on relationship between changes of plasma protein in pregnant women with severe preeclampsia and perinatal Outcomes

Retrospective analysis of perinatal outcomes of singleton pregnant women with early-onset severe preeclampsia superimposed on chronic hypertension

The perinatal examination and outcomes of 431 pregnancies complicated by severe preeclampsia

Clinical analysis on 78 cases with early onset severe preeclampsia